Producer

Molkem Chemicals Pvt Ltd

HQ IN · Gujarat

Indian fine-chemical / API maker with documented tapentadol API exports (Q2 2024).

1

Inputs supplied

1

Goods downstream

0

Facilities

0

Stories

What they make

1 input Molkem Chemicals Pvt Ltd supplies

Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.

Where it shows up

Goods downstream

Essential goods that depend on something Molkem Chemicals Pvt Ltd makes, pick one to see the full supply chain.

What else they do

Business segments

The company's full revenue map, where this supply-chain role fits within their broader business.

  • Fine chemicals, custom synthesis & APIs

Intelligence

What's known

Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.

  • Substitution2025

    Western buyers chasing 'pharma independence from China' by sourcing Indian APIs often get a product that isn't China-free upstream. India imports roughly 60–70% of its key starting materials, intermediates and solvents from China — which accounted for about 73.7% of India's ~$4.35B in API/intermediate imports in FY2024-25. So an 'Indian-made' tapentadol or fine chemical from a Gujarat maker can still be substantially Chinese one or two steps up the chain — a hidden dependency behind supply-chain-resilience narratives that India's ₹6,940-crore PLI bulk-drug scheme is explicitly trying to close. [verify: $4.35B FY25, China 73.7% ($3.20B) confirmed by DGCIS data]

    The Financial World
  • Did you know2024

    Molkem is a fine-chemical maker, not only an API house — and Gujarat fine-chemical / custom-synthesis plants are inherently dual-use. The same chemical-synthesis and high-purity-compound competency that produces a controlled-substance API like tapentadol also serves agrochemical intermediates, dyes, and specialty chemicals. The reactor train and the process know-how are the durable asset, not any single molecule, so a nominally 'pharma' supplier can pivot across regulated and unregulated chemistries depending on demand — which is exactly what makes fine-chemical capacity hard to police and easy to repurpose.

    Jay Fine Chem